Your browser is not supported.

To view this content, please use one of the following browsers:

  • Microsoft Edge
  • Chrome
  • Safari
  • Home
  • Lomentosporiosis

Lomentosporiosis

What is Lomentosporiosis?

Lomentosporiosis is a life-threatening invasive infection caused by Lomentospora prolificans (previously known as Scedosporium prolificans), an opportunistic pathogenic rare mould found in the soil.1–3 People who are immunocompromised or critically ill are at risk of infection.1,3

Pathogenesis

Lomentospora prolificans can cause invasive infection in the respiratory system, blood, central nervous system and other organs.1 Systemic infections can also occur.1 Clinical presentation includes pulmonary and cerebral manifestations, as well as disseminated disease with fungaemia.4

Epidemiology

Lomentospora prolificans is a globally distributed pathogen; however, an accurate estimate of the incidence of invasive lomentosporiosis is unknown due to scarcity of data.1 It is ubiquitously found as a soil saprophyte, predominantly in the arid climates of Australia, southwestern USA and Spain, which is reflected by the high number of reported cases in these regions.2

Invasive lomentosporiosis represents 13–33% of infections due to non-Aspergillus moulds, and an increase in cases of non-Aspergillus moulds such as lomentosporiosis has been reported in the past two decades.3

Invasive lomentosporiosis is associated with high mortality rates, estimated at 50–71% in adults and 50% in children who are immunocompromised.1

Risk factors

Risk factors for lomentosporiosis include:1,3

  • Critical illness
  • Immune deficiency
  • Haematological malignancy
  • Organ transplant

Pathogenic species

Lomentosporiosis is caused by Lomentospora prolificans.1,3

References

  1. WHO fungal priority pathogens list to guide research, development and public health action. Geneva: World Health Organization. Available at: https://www.who.int/publications/i/item/9789240060241. Accessed July 2023.
  2. Hoenigl M et al. Lancet Infect Dis. 2021;21:e246–e257.
  3. Bronnimann D et al. Med Mycol. 2021;59:486–497.
  4. Stemler J et al. J Antimicrob Chemother. 2022;77:253–258.

SciA-AFN-2400059 | November 2024